全球藥物發現資訊學市場規模、佔有率、成長分析（按工作流程、模式和服務）- 2024 年產業預測

2022年全球藥物發現資訊學市場規模為29.6億美元，從2023年的32.9億美元成長到77.6億美元，預測期間（2024-2031年）複合年成長率為11.30%。

In Silico建模技術的使用越來越多，藥物開發資料的增加，高效能運算和線上服務的日益複雜，以及對新藥物網站的需求不斷成長。由於這些因素，藥物發現資訊學市場預計在未來幾年將會成長。由於引入增強型藥物發現資訊技術，預計該行業的競爭將加劇。例如，2021 年 1 月，Certara, Inc. 宣布推出其 Simcyp 基於生理的藥物動力學 (PBPK) 模擬平台的第 20 版。這種新模型有助於評估和分析懷孕和哺乳期間的藥物使用。

此外，我們也協助做出關鍵選擇，以最大限度地提高您藥物的安全性和有效性。公司擴大轉向資訊技術來加速藥物開發。例如，Curve Therapeutics Ltd.計劃在2021年使用CDD Vault平台來管理其生物編碼的Microcycle平台。該平台是學術機構、生物技術公司和製藥行業常用的託管平台，透過安全、簡單和即時的資料共用來促進協作發現。

此外，全球COVID-19藥物發現進程進展更快，這正在推動市場擴張。例如，研究人員採用針對人類 ACE2 受體和病毒蛋白的 DrugBank 藥物進行虛擬篩檢，以提供快速治療方法。這些研究使用電腦方法來篩檢可用於尋找抗 COVID-19 藥物的小分子。

同樣，該公司正在創建一系列數位服務和解決方案，以支持 COVID-19 藥物開發的各個階段。例如，IBM Visual Molecular Explorer 平台檢查了一些針對冠狀病毒 (SARS-CoV-2) 的化學物質。 Explorers 促進了最佳藥物設計的早期階段，Explorer 是人工智慧生成工件的開放原始碼共用。

目錄

執行摘要

• 市場概況
• 命運之輪

調查方法

• 資訊採購
• 次要和主要資料來源
• 市場規模估算
• 市場假設與限制

母市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

主要市場考察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 主要投資分析
• 關鍵成功因素
• 競爭程度

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 監管環境
• 波特的分析
• 對未來中斷的特殊考慮

藥物發現資訊學的全球市場：按工作流程

• 市場概況
• 發現資訊學和開發資訊學

藥物發現資訊學的全球市場：按模式

• 市場概況
• 委託
• 公司內部

全球藥物發現資訊學市場：依服務分類

• 市場概況
• 序列分析平台
• 分子建模
• 對接
• 臨床試驗資料管理
• 其他服務

藥物發現資訊學的全球市場規模：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2021年）
• 主要市場參與者所採取的策略
• 關鍵成功策略
• 近期市集活動
• 主要企業市場佔有率（2021年）

主要企業簡介

• Accelrys（Biovia）
• SchrAﾂｶdinger
• Genedata
• OpenEye Scientific Software
• Certara
• Dotmatics
• Collaborative Drug Discovery（CDD）
• Optibrium
• Chemical Computing Group（CCG）
• IBM Watson Health
• PerkinElmer
• BioSolveIT
• Entelos
• Dassault SystAﾂｨmes Biovia
• XtalPi Inc.
• OpenText
• Benchling
• MedChemica Ltd.
• ChemAxon
• BioSymetrics Inc.

Global Drug Discovery Informatics Market size was valued at USD 2.96 Billion in 2022 and is poised to grow from USD 3.29 Billion in 2023 to USD 7.76 Billion, at a CAGR of 11.30 % during the forecast period (2024-2031).

In-silico modeling techniques are being used more often, drug development data is increasing, high-performance computing and online services are becoming more advanced, and there is a growing need for novel pharmaceutical moieties. These factors are expected to propel the drug discovery informatics market upward in the upcoming years. It is anticipated that industry competition would increase with the introduction of enhanced drug discovery information technology. For instance, in January 2021, Certara, Inc. launched version 20 of their Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulation platform. The new models facilitate the evaluation and analysis of pharmaceutical use during the course of pregnancy and lactation.

Moreover, it helps clients make important choices that maximize the safety and efficacy characteristics of drugs. Businesses are increasingly adopting informatics technology in an effort to shorten the time it takes to conduct drug development. For instance, Curve Therapeutics Ltd. will use the CDD Vault platform in 2021 to manage its biologically encoded Microcycle platform. It is a popular hosted platform used by academic institutions, biotechnology companies, and the pharmaceutical industry for safe, easy, real-time data sharing that fosters cooperative discoveries.

Additionally, the global Covid-19 drug discovery process is moving more quickly, which is fueling market expansion. For instance, researchers employed virtual screening using medications from the DrugBank to target human ACE2 receptors and viral proteins in order to deliver prompt remedies. These studies used silico approaches to screen for tiny molecules that could be useful in the search for anti-Covid-19 drugs.

In a same vein, businesses are creating an array of digital services and solutions to support the many phases of Covid-19 drug development. The IBM Visual Molecular Explorer platform, for instance, looked into a portion of the chemicals made that were directed against the coronavirus (SARS-CoV-2). The early phases of optimal drug design were facilitated by the explorer's open-source sharing of AI-generated artifacts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segmental Analysis

The global drug discovery informatics market is segmented based on workflow, mode, services, application, end-use, and region. In terms of workflow, the market is segmented into discovery informatics, and development informatics. On the basis of categorization by mode, the market is segmented into outsourced, and in-house. Based on services, the market is segmented into sequence analysis platforms, molecular modeling, docking, clinical trial data management, and other services. Based on region the global drug discovery informatics market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Drug Discovery Informatics Market

The demand for innovative pharmaceuticals has increased as a result of the rising prevalence of various diseases and the necessity for efficient treatment options. By facilitating effective data analysis, predictive modeling, and virtual screening, drug discovery informatics significantly contributes to the acceleration of the drug development process and consequently drives market growth.

Restraints in the Global Drug Discovery Informatics Market

Software licensing, hardware infrastructure, and trained staff are only a few of the significant upfront expenditures associated with implementing drug discovery informatics systems and technologies. Market expansion may be hindered by these high implementation costs, which may be an impediment for smaller businesses or organizations with tighter budgets.

Market Trends of the Global Drug Discovery Informatics Market

Growing Adoption of Machine Learning and Artificial Intelligence (AI and ML): In order to improve accuracy and efficiency, drug discovery informatics is incorporating AI and ML technologies more and more. Advanced data analysis, predictive modeling, and virtual screening are made possible by these technologies, which speed up the drug discovery process and increase success rates.

Growing Need for Cloud-Based Informatics Solutions: The drug discovery informatics industry has seen a notable increase in the use of cloud computing. With the scalability, flexibility, and affordability of cloud-based informatics solutions, businesses can effectively handle, store, and analyze massive amounts of data. They also make it easier for research teams to share data and collaborate remotely, which increases acceptance.

Emphasis on Targeted Therapies and customized Medicine: The market for drug discovery informatics has been impacted by the move toward targeted therapies and customized medicine. In order to find particular biomarkers, analyze patient data, and create customized treatments, informatics solutions are essential. Informatics tools for tailored drug discovery are being developed in response to the increasing focus on precision medicine.

Integration of Big Data Analytics: Big data analytics has been integrated into drug discovery informatics as a result of the availability of extensive genomic, proteomic, and clinical data. Researchers can uncover new therapeutic targets, get insightful knowledge, and streamline the drug development process by utilizing advanced analytics approaches including data mining, pattern recognition, and predictive modeling.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Drug Discovery Informatics Market by Workflow

• Market Overview
• Discovery Informatics and Development Informatics

Global Drug Discovery Informatics Market by Mode

• Market Overview
• Outsourced
• and In-house

Global Drug Discovery Informatics Market by Services

• Market Overview
• Sequence Analysis Platforms
• Molecular Modeling
• Docking
• Clinical Trial Data Management
• and Other Services

Global Drug Discovery Informatics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Accelrys (Biovia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SchrA¶dinger
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenEye Scientific Software
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dotmatics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collaborative Drug Discovery (CDD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optibrium
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemical Computing Group (CCG)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSolveIT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entelos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault SystA¨mes Biovia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XtalPi Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenText
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchling
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedChemica Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChemAxon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSymetrics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments